Basic info
Industry
biotechnology research
Sectors
Biotechnology
TLR 4/7 agonist
infectious diseases
anti-tumor agent
solid tumors
oncology
prophylactic vaccine for infectious diseases
innate immunity
Influenza
immuno-oncology
small molecules
pandemic preparedness
Date founded
2018
Funding rounds raised
Total raised
$13M
from 3 investors over 3 rounds
K
Kupando GmbH raised $13M on September 26, 2022
Investors: Remiges Ventures, Inc., Brandenburg Kapital GmbH and High-Tech Gründerfonds